Pediatric Rheumatology Online Journal (Jun 2023)

A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptations

  • Natoshia R. Cunningham,
  • Alaina Miller,
  • Samantha L. Ely,
  • Mallet R. Reid,
  • Ashley Danguecan,
  • Sarah I. Mossad,
  • Luana Flores Pereira,
  • Khalid Abulaban,
  • Elizabeth Kessler,
  • Natalie Rosenwasser,
  • Kabita Nanda,
  • Tamar Rubinstein,
  • Mathew Reeves,
  • Sara Ahola Kohut,
  • Jennifer Stinson,
  • Tala El Tal,
  • Deborah M. Levy,
  • Linda Hiraki,
  • Emily A. Smitherman,
  • Andrea M. Knight

DOI
https://doi.org/10.1186/s12969-023-00835-6
Journal volume & issue
Vol. 21, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Childhood-onset Systemic Lupus Erythematosus (cSLE) is an autoimmune disease associated with fatigue, mood symptoms, and pain. Fortunately, these symptoms are potentially modifiable with psychological intervention such as cognitive-behavioral therapy (CBT). The Treatment and Education Approach for Childhood-onset Lupus (TEACH) program is a CBT intervention developed to target these symptoms for adolescents and young adults with cSLE. This pilot randomized controlled trial (RCT) aims to determine the feasibility and effect of TEACH for youth with cSLE. Adjustments to the study protocol following the COVID-19 pandemic are also described. Methods This two-arm multisite RCT will explore the feasibility (primary outcome) and effect (secondary outcome) of a remotely delivered TEACH protocol. Participants will be randomized to a six-week remotely delivered TEACH program plus medical treatment as usual (TAU) or TAU alone. We will include patients ages 12–22 years presenting to rheumatology clinics from six sites. Validated measures of fatigue, depressive symptoms, and pain will be obtained at baseline and approximately eight and 20 weeks later. Protocol adjustments were also made due to the COVID-19 pandemic, in collaboration with the investigative team, which included patients and caregivers. Conclusions Findings from this multi-site RCT aim to document the feasibility of TEACH and provide an estimate of effect of a remotely delivered TEACH protocol on fatigue, depression, and pain symptoms in youth with cSLE as compared to standard medical treatment alone. This findings may positively impact clinical care for patients with cSLE. Clinical trials.gov registration: NCT04335643.

Keywords